Tengion Inc (TNGN) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
3929 WESTPOINT BLVD. WINSTON-SALEM, NC 27103 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 9/30/2014 MRQ | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 21,510,000 | 7,536,000 | |||
| Cash and cash equivalents | 21,510,000 | 7,536,000 | |||
| Restricted cash and investments | 1,000,000 | ||||
| Prepaid expense and other current assets | ✕ | 334,000 | 360,000 | ||
| Total current assets: | 21,844,000 | 8,896,000 | |||
| Noncurrent Assets | |||||
| Property, plant and equipment | 454,000 | 612,000 | |||
| Prepaid expense and other noncurrent assets | ✕ | 3,426,000 | 2,927,000 | ||
| Total noncurrent assets: | 3,880,000 | 3,539,000 | |||
| TOTAL ASSETS: | 25,724,000 | 12,435,000 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,976,000 | 2,814,000 | |||
| Employee-related liabilities | 757,000 | 716,000 | |||
| Accounts payable | 853,000 | 644,000 | |||
| Accrued liabilities | 2,366,000 | 1,454,000 | |||
| Debt | 1,994,000 | 2,322,000 | |||
| Derivative instruments and hedges, liabilities | 2,449,000 | ||||
| Other undisclosed current liabilities | 10,668,000 | 6,178,000 | |||
| Total current liabilities: | 16,638,000 | 13,763,000 | |||
| Noncurrent Liabilities | |||||
| Long-term debt and lease obligation | 25,930,000 | 10,007,000 | |||
| Long-term debt, excluding current maturities | 25,623,000 | 9,483,000 | |||
| Capital lease obligations | 307,000 | 524,000 | |||
| Liabilities, other than long-term debt | 12,000 | 8,000 | |||
| Other liabilities | 12,000 | 8,000 | |||
| Total noncurrent liabilities: | 25,942,000 | 10,015,000 | |||
| Total liabilities: | 42,580,000 | 23,778,000 | |||
| Equity | |||||
| Equity, attributable to parent, including: | (16,856,000) | (11,343,000) | |||
| Common stock | 7,000 | 2,000 | |||
| Additional paid in capital | 249,237,000 | 235,828,000 | |||
| Accumulated deficit | (266,100,000) | (247,173,000) | |||
| Warrants and rights outstanding | 11,425,000 | 6,178,000 | |||
| Other undisclosed equity, attributable to parent | (11,425,000) | (6,178,000) | |||
| Total equity: | (16,856,000) | (11,343,000) | |||
| TOTAL LIABILITIES AND EQUITY: | 25,724,000 | 12,435,000 | |||
Income Statement (P&L) (USD)
| 9/30/2014 TTM | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|
| Operating expenses | (16,597,000) | (16,220,000) | ||
| Other operating income, net (Other Expenses) | 555,000 | 165,000 | ||
| Operating loss: | (16,042,000) | (16,055,000) | ||
| Nonoperating income (Investment Income, Nonoperating) | 47,000 | 27,000 | ||
| Interest and debt expense | (7,622,000) | (2,957,000) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 7,020,000 | |||
| Loss from continuing operations: | (16,597,000) | (18,985,000) | ||
| Loss before gain (loss) on sale of properties: | (16,597,000) | (18,985,000) | ||
| Net loss: | (16,597,000) | (18,985,000) | ||
| Other undisclosed net income (loss) attributable to parent | (2,330,000) | 2,056,000 | ||
| Net loss available to common stockholders, diluted: | (18,927,000) | (16,929,000) | ||
Comprehensive Income (USD)
| 9/30/2014 TTM | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|
| Net loss: | (16,597,000) | (18,985,000) | ||
| Comprehensive loss: | (16,597,000) | (18,985,000) | ||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (2,330,000) | |||
| Comprehensive loss, net of tax, attributable to parent: | (18,927,000) | (18,985,000) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.